Two Sigma Investments’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$620K Sell
346,382
-119,127
-26% -$253K ﹤0.01% 3585
2025
Q4
$1.04M Buy
465,509
+366,227
+369% +$963K ﹤0.01% 2881
2025
Q3
$240K Buy
99,282
+28,583
+40% +$76.1K ﹤0.01% 3309
2025
Q2
$41.9K Buy
+70,699
New +$55K ﹤0.01% 3083

Other funds holding PROK

Two Sigma Investments's PROK Position: Q1 2026 in Review

Two Sigma Investments reduced its ProKidney (PROK) stake by 26% in Q1 2026, selling an estimated $253K and leaving 346,382 shares worth $620K. The position accounts for ﹤0.01% of the portfolio, ranked #3585.

Two Sigma Investments first reported a position in PROK in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.04M in Q4 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Two Sigma Investments held 346,382 shares of ProKidney worth $620K as of Q1 2026.
  • Two Sigma Investments sold 119,127 ProKidney shares in Q1 2026, an estimated $253K.
  • ProKidney made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3585 holding.
  • Two Sigma Investments first reported a position in ProKidney in Q2 2025 and has held it in 4 quarters since.
  • Two Sigma Investments's ProKidney position peaked at $1.04M in Q4 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.